BioCryst Appoints David W. Jenkins as Chief Scientific Officer

Go back to BioCryst Appoints David W. Jenkins as Chief Scientific Officer
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.39 -0.12 (1.26%)
Previous Close $9.51    52 Week High $10.98 
Open $9.32    52 Week Low $1.63 
Day High $9.48    P/E N/A 
Day Low $9.25    EPS $-0.68 
Volume 827,910